Related Experiment Video
Updated: May 3, 2026

MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
RNAi and miRNA in viral infections and cancers
Hamid Reza Mollaie1, Seyed Hamid Reza Monavari, Seyed Ali Mohammad Arabzadeh
1Department of Virology, Iran University of Medical Sciences, Tehran, Iran
Abstract:
Since the first report of RNA interference (RNAi) less than a decade ago, this type of molecular intervention has been introduced to repress gene expression in vitro and also for in vivo studies in mammals. Understanding the mechanisms of action of synthetic small interfering RNAs (siRNAs) underlies use as therapeutic agents in the areas of cancer and viral infection. Recent studies have also promoted different theories about cell-specific targeting of siRNAs. Design and delivery strategies for successful treatment of human diseases are becomingmore established and relationships between miRNA and RNAi pathways have been revealed as virus-host cell interactions. Although both are well conserved in plants, invertebrates and mammals, there is also variabilityand a more complete understanding of differences will be needed for optimal application. RNA interference (RNAi) is rapid, cheap and selective in complex biological systems and has created new insight sin fields of cancer research, genetic disorders, virology and drug design. Our knowledge about the role of miRNAs and siRNAs pathways in virus-host cell interactions in virus infected cells is incomplete. There are different viral diseases but few antiviral drugs are available. For example, acyclovir for herpes viruses, alpha-interferon for hepatitis C and B viruses and anti-retroviral for HIV are accessible. Also cancer is obviously an important target for siRNA-based therapies, but the main problem in cancer therapy is targeting metastatic cells which spread from the original tumor. There are also other possible reservations and problems that might delay or even hinder siRNA-based therapies for the treatment of certain conditions; however, this remains the most promising approach for a wide range of diseases. Clearly, more studies must be done to allow efficient delivery and better understanding of unwanted side effects of siRNA-based therapies. In this review miRNA and RNAi biology, experimental design, anti-viral and anti-cancer effects are discussed.
Insights
RNA interference (RNAi) and microRNA (miRNA) pathways offer promising therapeutic strategies for cancer and viral infections. Further research is needed to optimize delivery and understand side effects for effective clinical application.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- RNA interference (RNAi) and microRNA (miRNA) are conserved gene regulation pathways with therapeutic potential.
- Understanding siRNA mechanisms is crucial for developing treatments for cancer and viral infections.
- The interplay between viral and host cell pathways involving RNAi and miRNA is not fully understood.
Purpose of the Study:
- To review the biology of miRNA and RNAi pathways.
- To discuss experimental design for RNAi-based therapies.
- To explore the anti-viral and anti-cancer effects of RNAi.
Main Methods:
- Literature review of RNAi and miRNA research.
- Analysis of current therapeutic strategies and challenges.
- Discussion of virus-host interactions and gene silencing.
Main Results:
- RNAi is a rapid, selective, and cost-effective tool for gene regulation in biological systems.
- siRNA-based therapies show promise for cancer and viral diseases, but challenges in targeting and delivery remain.
- miRNA and RNAi pathways play significant roles in virus-host interactions.
Conclusions:
- RNAi and miRNA pathways are powerful tools with broad applications in research and medicine.
- Optimizing siRNA delivery and understanding potential side effects are critical for clinical success.
- Further research into viral-host interactions mediated by these pathways is essential for developing novel antiviral therapies.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
MicroRNAs
MicroRNAs
MicroRNAs
Experimental RNAi

